Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04063397 · ClinicalTrials.gov registry record
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
A clinical trial of Preeclampsia Severe or Mild and Cardiac Complication, sponsored by Ohio State University.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT04063397: Completed study of Preeclampsia Severe or Mild and Cardiac Complication, sponsored by Ohio State University.
NCT04063397 is a study of Preeclampsia Severe or Mild and Cardiac Complication that has completed, run by Ohio State University. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04063397, a study of Preeclampsia Severe or Mild and Cardiac Complication, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes.
Primary Outcome
The following parameters will be measured to assess cardiac dysfunction: 1. LV Size/function 1. Biplane Method of Disks LVEF (a4C and 2C views for EDV and ESV) 2. LV Fractional shortening- Septal thickness and PW thickness 3. LV Strain- Basal longitudinal, Mid LV longitudinal, Apical LV longitudinal and Global LV longitudinal strain 4. 3D LV EF 5. Tei index 6. Analysis of LV diastolic function- Mitral E wave, Mitral A wave, Mitral e', Mitral E/e', Mitral E/A and Mitral Decel
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood draw
- DIAGNOSTIC_TEST Echocardiogram
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2023-12-14 |
What the finished NCT04063397 record still lists
NCT04063397 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 2 conditions, with Preeclampsia Severe or Mild appearing as the primary indexed condition, and to 2 interventions - of which Blood draw is the first listed.
NCT04063397 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04063397 about?
NCT04063397 is a clinical study titled "Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia". The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to e...
What is the current status of trial NCT04063397?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2019-08-19. Estimated completion is 2023-12-14.
What conditions does trial NCT04063397 study?
This clinical trial studies the following conditions: Preeclampsia Severe or Mild, Cardiac Complication.
What interventions are being tested in trial NCT04063397?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Echocardiogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04063397?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04063397 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI